Bailard Inc. cut its stake in shares of Ingredion Incorporated (NYSE:INGR - Free Report) by 46.8% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 3,048 shares of the company's stock after selling 2,677 shares during the quarter. Bailard Inc.'s holdings in Ingredion were worth $419,000 at the end of the most recent quarter.
A number of other institutional investors and hedge funds have also made changes to their positions in the stock. Patriot Financial Group Insurance Agency LLC grew its stake in shares of Ingredion by 1.8% during the 4th quarter. Patriot Financial Group Insurance Agency LLC now owns 4,162 shares of the company's stock worth $572,000 after purchasing an additional 74 shares during the period. Transcend Capital Advisors LLC grew its stake in shares of Ingredion by 2.1% during the 4th quarter. Transcend Capital Advisors LLC now owns 4,318 shares of the company's stock worth $594,000 after purchasing an additional 90 shares during the period. Truist Financial Corp grew its stake in shares of Ingredion by 1.3% during the 4th quarter. Truist Financial Corp now owns 6,854 shares of the company's stock worth $943,000 after purchasing an additional 90 shares during the period. Tidal Investments LLC grew its stake in shares of Ingredion by 0.5% during the 3rd quarter. Tidal Investments LLC now owns 19,905 shares of the company's stock worth $2,720,000 after purchasing an additional 94 shares during the period. Finally, Wealth Enhancement Advisory Services LLC grew its stake in shares of Ingredion by 0.9% during the 4th quarter. Wealth Enhancement Advisory Services LLC now owns 10,383 shares of the company's stock worth $1,427,000 after purchasing an additional 97 shares during the period. 85.27% of the stock is owned by institutional investors and hedge funds.
Insider Buying and Selling at Ingredion
In other news, CEO James P. Zallie sold 10,815 shares of the company's stock in a transaction dated Wednesday, February 19th. The shares were sold at an average price of $125.88, for a total transaction of $1,361,392.20. Following the completion of the transaction, the chief executive officer now owns 34,127 shares of the company's stock, valued at $4,295,906.76. This represents a 24.06 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. 1.80% of the stock is owned by insiders.
Ingredion Trading Up 3.4 %
NYSE:INGR traded up $4.50 on Friday, reaching $135.54. The stock had a trading volume of 913,740 shares, compared to its average volume of 593,819. The company has a market cap of $8.70 billion, a price-to-earnings ratio of 13.96, a P/E/G ratio of 1.03 and a beta of 0.74. The company has a debt-to-equity ratio of 0.47, a current ratio of 2.62 and a quick ratio of 1.69. The firm's fifty day moving average is $132.08 and its two-hundred day moving average is $136.54. Ingredion Incorporated has a 12-month low of $109.51 and a 12-month high of $155.44.
Ingredion (NYSE:INGR - Get Free Report) last released its earnings results on Tuesday, February 4th. The company reported $2.63 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $2.54 by $0.09. The company had revenue of $1.80 billion for the quarter, compared to analyst estimates of $1.82 billion. Ingredion had a net margin of 8.71% and a return on equity of 18.62%. The firm's quarterly revenue was down 6.3% on a year-over-year basis. During the same period in the prior year, the firm earned $1.65 EPS. Equities analysts expect that Ingredion Incorporated will post 11.14 EPS for the current fiscal year.
Ingredion Dividend Announcement
The company also recently announced a quarterly dividend, which was paid on Tuesday, January 21st. Shareholders of record on Thursday, January 2nd were issued a $0.80 dividend. The ex-dividend date was Thursday, January 2nd. This represents a $3.20 dividend on an annualized basis and a yield of 2.36%. Ingredion's dividend payout ratio (DPR) is 32.96%.
Analyst Upgrades and Downgrades
A number of research firms have recently weighed in on INGR. StockNews.com cut shares of Ingredion from a "strong-buy" rating to a "buy" rating in a research note on Thursday, February 6th. UBS Group boosted their price objective on shares of Ingredion from $165.00 to $173.00 and gave the stock a "buy" rating in a research report on Friday, November 15th. Stephens decreased their price objective on shares of Ingredion from $155.00 to $150.00 and set an "equal weight" rating on the stock in a research report on Wednesday, February 5th. Oppenheimer decreased their price objective on shares of Ingredion from $178.00 to $167.00 and set an "outperform" rating on the stock in a research report on Wednesday, February 5th. Finally, BMO Capital Markets decreased their price objective on shares of Ingredion from $147.00 to $133.00 and set a "market perform" rating on the stock in a research report on Wednesday, February 5th. Two research analysts have rated the stock with a hold rating and four have given a buy rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and an average price target of $158.20.
Get Our Latest Report on Ingredion
Ingredion Company Profile
(
Free Report)
Ingredion Incorporated, together with its subsidiaries, manufactures and sells sweeteners, starches, nutrition ingredients, and biomaterial solutions derived from wet milling and processing corn, and other starch-based materials to a range of industries in North America, South America, the Asia Pacific, Europe, the Middle East, and Africa.
Read More

Before you consider Ingredion, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ingredion wasn't on the list.
While Ingredion currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.